Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Publication year range
1.
Clin Calcium ; 23(12): 1789-94, 2013 Dec.
Article in Japanese | MEDLINE | ID: mdl-24292534

ABSTRACT

Skeletal dysplasia is the term which represents disorders including growth and differentiation of bone, cartilage and ligament. A lot of diseases are included, and new disorders have been added. However, the therapy of most bone diseases is less well-established. Achondroplasia, hypochondroplasia, and osteogenesis imperfecta are most frequent bone diseases. There is no curative treatment for these diseases, however, supportive therapies are available ; for example, growth-hormone therapy for achondroplasia and hypochondroplasia, and bisphosphonate therapy for osteogenesis imperfecta. In addition, enzyme replacement therapy for hypophosphatasia is now on clinical trial.


Subject(s)
Achondroplasia/therapy , Bone and Bones/abnormalities , Dwarfism/therapy , Limb Deformities, Congenital/therapy , Lordosis/therapy , Osteogenesis Imperfecta/therapy , Achondroplasia/etiology , Alkaline Phosphatase/administration & dosage , Animals , Bone Density Conservation Agents/administration & dosage , Collagen Type I/genetics , Collagen Type I, alpha 1 Chain , Diphosphonates/administration & dosage , Dwarfism/etiology , Humans , Hypophosphatasia/etiology , Hypophosphatasia/therapy , Limb Deformities, Congenital/etiology , Lordosis/etiology , Mice , Molecular Targeted Therapy , Mutation , Natriuretic Peptide, C-Type/administration & dosage , Natriuretic Peptide, C-Type/analogs & derivatives , Osteogenesis Imperfecta/classification , Osteogenesis Imperfecta/etiology , Pamidronate , Receptor, Fibroblast Growth Factor, Type 3/genetics , Recombinant Proteins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...